A. Shete

发表

Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia

Roberto C. Mirasol, M. Chawla, Tae Ho Kim, 2018, Current medical research and opinion.

Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis

D. Gladman, A. Deodhar, I. McInnes, 2019, The Journal of Rheumatology.

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

B. Elewski, M. Lebwohl, E. Soriano, 2020, JAMA dermatology.

Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long‐Term Results of Two Phase III Randomized Controlled Trials

V. Strand, A. Deodhar, P. Conaghan, 2020, Arthritis care & research.

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

A. Deodhar, L. Gensler, J. Braun, 2021, Arthritis Research & Therapy.

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

M. Lebwohl, C. Griffiths, A. Deodhar, 2021, The British journal of dermatology.

Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan.

Rajiv Khanna, P. Shah, S. Shaikh, 2013, World journal of diabetes.

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

M. Lebwohl, C. Griffiths, P. Primatesta, 2021, British Journal of Dermatology.

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

D. Gladman, A. Deodhar, J. Rosenbaum, 2020, ACR open rheumatology.

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

A. Gottlieb, M. Lebwohl, A. Deodhar, 2022, Acta dermato-venereologica.

Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies

A. Deodhar, L. Gensler, A. Winseck, 2021, The Journal of Rheumatology.

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

B. Cho, S. Assaad-Khalil, K. Ueng, 2015, Vascular health and risk management.

Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study

B. Cho, S. Assaad-Khalil, K. Ueng, 2014, Current medical research and opinion.